|
| 37875127 | Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort study. | Eur Heart J Acute Cardiovasc Care | 2024 |
| 37875127 | Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort study. | Eur Heart J Acute Cardiovasc Care | 2024 |
| 35980763 | A polygenic risk score predicts atrial fibrillation in cardiovascular disease. | Eur Heart J | 2023 |
| 36303404 | Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis. | Eur Heart J | 2023 |
| 35980763 | A polygenic risk score predicts atrial fibrillation in cardiovascular disease. | Eur Heart J | 2023 |
| 37606673 | Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events. | JAMA | 2023 |
| 37930059 | Serial Assessment of Shock Severity in Cardiac Intensive Care Unit Patients. | J Am Heart Assoc | 2023 |
| 37648656 | In-perspective: the ARAMIS double-blind randomized placebo-controlled trial of anakinra for the treatment of acute myocarditis. | Eur Heart J Acute Cardiovasc Care | 2023 |
| 37640029 | Prognostic significance of haemodynamic parameters in patients with cardiogenic shock. | Eur Heart J Acute Cardiovasc Care | 2023 |
| 37782695 | Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC). | Circulation | 2023 |
| 37556796 | Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes. | Diabetes Care | 2023 |
| 38057075 | Research Priorities in Critical Care Cardiology: JACC Expert Panel. | J Am Coll Cardiol | 2023 |
| 36521683 | Characteristics, therapies, and outcomes of In-Hospital vs Out-of-Hospital cardiac arrest in patients presenting to cardiac intensive care units: From the critical care Cardiology trials network (CCCTN). | Resuscitation | 2023 |
| 37217982 | High-sensitivity cardiac troponin in stable atherosclerotic vascular disease. | Eur Heart J Acute Cardiovasc Care | 2023 |
| 36779177 | Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry. | Am Heart J Plus | 2023 |
| 36592046 | IGFBP-7 and Outcomes in Heart Failure With Reduced Ejection Fraction: Findings From DAPA-HF. | JACC Heart Fail | 2023 |
| 37407113 | Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure. | J Am Coll Cardiol | 2023 |
| 37344040 | Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus. | J Am Coll Cardiol | 2023 |
| 37212758 | Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure. | J Am Coll Cardiol | 2023 |
| 36585901 | Acute cardiovascular care in the emergency department and beyond: a call for interdisciplinary collaboration in clinical research. | Eur Heart J Acute Cardiovasc Care | 2023 |
| 37468189 | Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation. | J Am Coll Cardiol | 2023 |
| 37211048 | Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: Analyses from ENGAGE AF- TIMI 48 trial. | Int J Cardiol | 2023 |
| 37210743 | Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF. | Eur Heart J | 2023 |
| 37017087 | Longitudinal Trends in Cardiovascular Risk Factor Profiles and Complications Among Patients Hospitalized for COVID-19 Infection: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. | Circ Cardiovasc Qual Outcomes | 2023 |
| 36708205 | On the brink of the new year, on the brink of a new era: European Heart Journal Acute CardioVascular Care goes online only. | Eur Heart J Acute Cardiovasc Care | 2023 |
| 36882069 | Outcomes in high-risk pulmonary embolism patients undergoing FlowTriever mechanical thrombectomy: the FLAME study in perspective. | Eur Heart J Acute Cardiovasc Care | 2023 |
| 37454754 | A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH). | Am Heart J | 2023 |
| 37260728 | Deep vein thrombosis as thrombotic sequelae of vaccine-induced thrombotic thrombocytopenia. | Oxf Med Case Reports | 2023 |
| 37318422 | Pulmonary Artery Catheter Use and Mortality in the Cardiac Intensive Care Unit. | JACC Heart Fail | 2023 |
| 37259183 | Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers. | Eur Heart J | 2023 |
| 37257452 | Single-cell transcriptomics reveal a hyperacute cytokine and immune checkpoint axis after cardiac arrest in patients with poor neurological outcome. | Med | 2023 |
| 37381988 | Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial. | Arterioscler Thromb Vasc Biol | 2023 |
| 37253080 | Cultivating the Research Landscape for Critical Care Cardiology: The Case for Registry-Based Randomized Controlled Trials. | Circulation | 2023 |
| 37184336 | Advances in the Management of Cardiogenic Shock. | Crit Care Med | 2023 |
| 36691960 | Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2°P-TIMI 50 trial. | Clin Cardiol | 2023 |
| 36796671 | Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event. | J Card Fail | 2023 |
| 36537212 | Prognostic interpretation of serial high-sensitivity cardiac troponin in patients presenting with suspected acute coronary syndrome. | Eur Heart J | 2023 |
| 36857061 | Critical Appraisal of the Negative Predictive Performance of the European Society of Cardiology 0/1-Hour Algorithm for Evaluating Patients With Chest Pain in the US. | JAMA Cardiol | 2023 |
| 36857035 | Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes: A Secondary Analysis of the DECLARE-TIMI 58 Trial. | JAMA Cardiol | 2023 |
| 36458542 | Clinician and Algorithmic Application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network Registry. | Circ Heart Fail | 2023 |
| 37039015 | Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF. | Circulation | 2023 |
| 37038327 | Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation. | Eur Heart J | 2023 |
| 37037002 | CHANGES IN VASOACTIVE DRUG REQUIREMENTS AND MORTALITY IN CARDIAC INTENSIVE CARE UNIT PATIENTS. | Shock | 2023 |
| 36987929 | Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillation. | Eur J Heart Fail | 2023 |
| 36669711 | Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry. | Am Heart J | 2023 |
| 37539538 | Family Engagement in the Adult Cardiac Intensive Care Unit: A Survey of Family Engagement Practices in the Cardiac Critical Care Trials Network. | Circ Cardiovasc Qual Outcomes | 2023 |
| 37494772 | Frequency, compliance, and yield of cardiac testing after high-sensitivity troponin accelerated diagnostic protocol implementation. | Am J Emerg Med | 2023 |
| 36597721 | Bridging strategies and cardiac replacement outcomes in patients with acute decompensated heart failure-related cardiogenic shock. | Eur J Heart Fail | 2023 |
| 37556796 | Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes. | Diabetes Care | 2023 |
| 38057075 | Research Priorities in Critical Care Cardiology: JACC Expert Panel. | J Am Coll Cardiol | 2023 |